Loading...

NEUMORA THERAPEUTICS, INC. COMMON STOCK

2024 2nd Quarter
1st Quarter
2023 4th Quarter
3rd Quarter
2nd Quarter
1st Quarter
2022 4th Quarter
3rd Quarter

Use left/right arrow keys to switch.

Breakdowns

Name	Value
Revenues	0.0M
Cost of Revenue	1.0M
Gross Profit	-1.0M
Operating Expense	42.1M
Operating I/L	-42.1M
Other Income/Expense	-0.0M
Interest Income	3.6M
Pretax	-38.5M
Income Tax Expense	-3.6M
Net Income/Loss	-38.5M

Neumora Therapeutics, Inc. Common Stock

Trending Profiles

Meta Platforms, Inc.

META

Alphabet Inc.

GOOG

Tesla, Inc.

TSLA

Amazon.com, Inc.

AMZN

NVIDIA Corporation

NVDA

Apple Inc.

AAPL

This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.